<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00407914</url>
  </required_header>
  <id_info>
    <org_study_id>CONAQ-US01</org_study_id>
    <nct_id>NCT00407914</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness of Aquamid as Compared to Restylane for the Aesthetic Treatment of Nasolabial Folds</brief_title>
  <official_title>A Double-Masked, Randomized, Multi-Center, 2-Arm Parallel Study Comparing the Safety and Effectiveness of Aquamid and Restylane for the Aesthetic Treatment of Nasolabial Folds</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Contura</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Contura</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effectiveness of Aquamid and Restylane in
      aesthetically enhancing nasolabial folds 6 months after treatment and to evaluate the safety
      of Aquamid through 12 months after treatment.

      The study includes an extended follow up to 24 months.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wrinkle Assessment Scale</measure>
    <time_frame>Baseline, 3, 6, 9, 12 Months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse device effects</measure>
    <time_frame>continuosly</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Global Aesthetic Improvement Scale</measure>
    <time_frame>Optimal treatment, 3, 6, 9 and 12 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Injection site reactions</measure>
    <time_frame>After injection</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>continuosly</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">315</enrollment>
  <condition>Facial Wrinkles</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aquamid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Restylane</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Aquamid</intervention_name>
    <description>Subcutaneous injection</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Restylane</intervention_name>
    <description>Injection in dermis</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  interested on soft tissue augmentation for the nasolabial folds

          -  moderate to severe nasolabial fold

        Exclusion Criteria:

          -  sensitivity to anesthetics

          -  allergy to hyaluronic acid

          -  previous treatment with permanent fillers in the treated area

          -  recent previous aesthetic procedure in the treatment area

          -  infected skin areas or autoimmune diseases affecting the skin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Silvia Codony</last_name>
    <role>Study Director</role>
    <affiliation>Contura</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>White Plains</city>
        <state>New York</state>
        <zip>10604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>von Buelow S, von Heimburg D, Pallua N. Efficacy and safety of polyacrylamide hydrogel for facial soft-tissue augmentation. Plast Reconstr Surg. 2005 Sep 15;116(4):1137-46; discussion 1147-8.</citation>
    <PMID>16163108</PMID>
  </reference>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 4, 2006</study_first_submitted>
  <study_first_submitted_qc>December 4, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2006</study_first_posted>
  <disposition_first_submitted>July 1, 2009</disposition_first_submitted>
  <disposition_first_submitted_qc>October 6, 2009</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">October 8, 2009</disposition_first_posted>
  <last_update_submitted>October 6, 2009</last_update_submitted>
  <last_update_submitted_qc>October 6, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 8, 2009</last_update_posted>
  <responsible_party>
    <name_title>Silvia G Codony, Clinical Research Director</name_title>
    <organization>Contura</organization>
  </responsible_party>
  <keyword>wrinkles</keyword>
  <keyword>soft tissue filler</keyword>
  <keyword>Aquamid</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

